
TY  - JOUR
TI  - Abstracts-Posters
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Res
VL  - 39
IS  - S1
SN  - 0145-6008
UR  - https://doi.org/10.1111/acer.12741
DO  - doi:10.1111/acer.12741
SP  - 12A
EP  - 249A
PY  - 2015
ER  - 

TY  - JOUR
TI  - ASBMR 29th Annual Meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 22
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650221403
DO  - doi:10.1002/jbmr.5650221403
SP  - s52
EP  - s101
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstract for POSTER presentation
JO  - International Journal of Urology
VL  - 17
IS  - s1
SN  - 0919-8172
UR  - https://doi.org/10.1111/j.1442-2042.2010.02649.x
DO  - doi:10.1111/j.1442-2042.2010.02649.x
SP  - A247
EP  - A383
PY  - 2010
ER  - 

TY  - JOUR
TI  - 2019 Annual Meeting of the American Society for Bone and Mineral Research Orange County Convention Center, Orlando, Florida, USA September 20–23, 2019
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 34
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.3936
DO  - doi:10.1002/jbmr.3936
SP  - S1
EP  - S442
PY  - 2019
ER  - 

TY  - JOUR
TI  - 2015 Annual Meeting of the American Society for Bone and Mineral Research Seattle, WA October 9–12, 2015
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 30
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.2763
DO  - doi:10.1002/jbmr.2763
SP  - S1
EP  - S1
PY  - 2015
AB  - ABSTRACT Searchable abstracts may be found at http://www.asbmr.org/education/abstracts
ER  - 

TY  - JOUR
TI  - Concurrent Sessions Posters
JO  - HPB
JA  - HPB
VL  - 15
IS  - s2
SN  - 1365-182X
UR  - https://doi.org/10.1111/hpb.12093
DO  - doi:10.1111/hpb.12093
SP  - 85
EP  - 244
PY  - 2013
ER  - 

TY  - JOUR
TI  - 37th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)
JO  - Experimental Dermatology
VL  - 19
IS  - 2
SN  - 0906-6705
UR  - https://doi.org/10.1111/j.1600-0625.2009.01051.x
DO  - doi:10.1111/j.1600-0625.2009.01051.x
SP  - 166
EP  - 232
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Alcoholism: Clinical and Experimental Research
VL  - 36
IS  - s2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2012.01917.x
DO  - doi:10.1111/j.1530-0277.2012.01917.x
SP  - 1A
EP  - 152A
PY  - 2012
ER  - 

TY  - JOUR
AU  - Patel, Rajkumar
AU  - Patel, Madhumita
AU  - Kwak, Jeonghun
AU  - Iyer, Arun K.
AU  - Karpoormath, Rajshekhar
AU  - Desai, Shrojal
AU  - Rarh, Vimal
C8  - PAT-17-191
TI  - Polymeric microspheres: a delivery system for osteogenic differentiation
JO  - Polymers for Advanced Technologies
JA  - Polym. Adv. Technol.
VL  - 28
IS  - 12
SN  - 1042-7147
UR  - https://doi.org/10.1002/pat.4084
DO  - doi:10.1002/pat.4084
SP  - 1595
EP  - 1609
KW  - microspheres
KW  - bone regeneration
KW  - PLGA
KW  - fibroblast growth factor
KW  - bone morphogenetic protein
KW  - bone tissue engineering
PY  - 2017
AB  - Advanced drug delivery systems employing controlled release technology are being developed to address many of the difficulties associated with traditional methods of drug administration. Controlled release technology involves the use of devices such as polymer-based disks, rods, pellets, or microspheres (MSs) that encapsulate drugs, genes, cytokines, and growth factors and release them in specific location within the body in a controlled fashion, for relatively long periods of time. Among these, microencapsulation is one of the core technologies used in polymer-based drug delivery systems. In this regard, MS serves as microcarriers for sustain drug release facilitating their use for invasive or minimally invasive treatment. MS has significant potential for the application in bone repair, intra-articular treatment of osteoarthritis, and biological bone growth. The present review compiles the recent advances in polymeric MS for application in bone and cartilage regeneration. Copyright ? 2017 John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Proceedings of the VI National Congress of Pharmacology October 2009 – Posters
JO  - Autonomic and Autacoid Pharmacology
VL  - 30
IS  - 1
SN  - 1474-8665
UR  - https://doi.org/10.1111/j.1474-8673.2009.00450.x
DO  - doi:10.1111/j.1474-8673.2009.00450.x
SP  - 1
EP  - 65
PY  - 2010
ER  - 

TY  - JOUR
TI  - FREE COMMUNICATIONS  POSTER COMMUNICATIONS
JO  - Nephrology
VL  - 10
IS  - s1
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2005.00420.x
DO  - doi:10.1111/j.1440-1797.2005.00420.x
SP  - A117
EP  - A232
PY  - 2005
ER  - 

TY  - JOUR
TI  - Free Papers
JO  - Journal of Gastroenterology and Hepatology
VL  - 19
IS  - s5
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2004.t01-1-03624.x
DO  - doi:10.1111/j.1440-1746.2004.t01-1-03624.x
SP  - A296
EP  - A323
PY  - 2004
ER  - 

TY  - JOUR
TI  - AASLD Abstracts
JO  - Hepatology
JA  - Hepatology
VL  - 58
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.26727
DO  - doi:10.1002/hep.26727
SP  - 208A
EP  - 1309A
PY  - 2013
ER  - 

TY  - JOUR
AU  - Awasthi, Harshika
AU  - Mani, Dayanandan
AU  - Singh, Divya
AU  - Gupta, Atul
TI  - The underlying pathophysiology and therapeutic approaches for osteoporosis
JO  - Medicinal Research Reviews
JA  - Med Res Rev
VL  - 38
IS  - 6
SN  - 0198-6325
UR  - https://doi.org/10.1002/med.21504
DO  - doi:10.1002/med.21504
SP  - 2024
EP  - 2057
KW  - anabolic agents
KW  - antiresorptive therapies
KW  - novel targets
KW  - osteoporosis
KW  - pathophysiology
KW  - triggers and targets
PY  - 2018
AB  - Abstract With an increase in the ageing population worldwide, the prevalence of osteoporosis increases at an alarming rate in both male and female irrespective of their ethnicity. At present, the currently available therapeutic options are mostly limited to either bone resorptive or bone forming efficacies and both approaches are associated with serious side effects. Despite these options, there is still need for newer therapeutics to treat osteoporosis, which can offer beneficial effects for maintaining balanced dynamics between bone formation and bone resorption, devoid of any side effect. The proper understanding of pathophysiology of the disease is essential for designing or investigating an effective and safe anti-osteoporotic agent. This review represents a discussion around the molecular targets with their implications in disease progression, available therapeutic options, the emerging targets, and the importance of designing an effective anti-osteoporotic agent.
ER  - 

TY  - JOUR
TI  - Abstracts 200–407
JO  - Hepatology
JA  - Hepatology
VL  - 52
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.23979
DO  - doi:10.1002/hep.23979
SP  - 422A
EP  - 522A
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster
JO  - Journal of Hepato-Biliary-Pancreatic Sciences
JA  - J Hepatobiliary Pancreat Sci
VL  - 24
IS  - S1
SN  - 1868-6974
UR  - https://doi.org/10.1002/jhbp.480
DO  - doi:10.1002/jhbp.480
SP  - A235
EP  - A394
PY  - 2017
ER  - 

TY  - JOUR
TI  - ASBMR 26th Annual Meeting SA001–SA589
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 19
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650191304
DO  - doi:10.1002/jbmr.5650191304
SP  - S108
EP  - S204
PY  - 2004
ER  - 

TY  - JOUR
TI  - 2017 Annual Meeting of the American Society for Bone and Mineral Research, Colorado Convention Center, Denver, CO, USA — September 8–11, 2017
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 32
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.3363
DO  - doi:10.1002/jbmr.3363
SP  - S1
EP  - S432
PY  - 2017
ER  - 

TY  - JOUR
TI  - LECTURES
JO  - Acta Paediatrica
VL  - 97
IS  - s459
SN  - 0803-5253
UR  - https://doi.org/10.1111/j.1651-2227.2008.00841.x
DO  - doi:10.1111/j.1651-2227.2008.00841.x
SP  - 1
EP  - 259
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Urology
VL  - 19
IS  - s1
SN  - 0919-8172
UR  - https://doi.org/10.1111/j.1442-2042.2012.03167.x
DO  - doi:10.1111/j.1442-2042.2012.03167.x
SP  - 5
EP  - 458
PY  - 2012
ER  - 
